Clinical Trial Update: Long-Term Intermittent Administration of Levosimendan in Patients With Advanced Heart Failure [Phase 4]

View source ↗

Summary

This clinical trial update discusses a Phase 4 study of long-term intermittent administration of levosimendan in patients with advanced heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Levosimendan (levosimendan)

Snippet

Sponsor: Hospital Universitario de Canarias | Conditions: Advanced Heart Failure | Phase 4 | Status: UNKNOWN